These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21699179)

  • 21. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
    Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
    J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner.
    Weng L; Hirata Y; Arai M; Kohara M; Wakita T; Watashi K; Shimotohno K; He Y; Zhong J; Toyoda T
    J Virol; 2010 Nov; 84(22):11761-70. PubMed ID: 20844041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
    Murakami E; Niu C; Bao H; Micolochick Steuer HM; Whitaker T; Nachman T; Sofia MA; Wang P; Otto MJ; Furman PA
    Antimicrob Agents Chemother; 2008 Feb; 52(2):458-64. PubMed ID: 17999967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flavone inspired discovery of benzylidenebenzofuran-3(2H)-ones (aurones) as potent inhibitors of human protein kinase CK2.
    Protopopov MV; Vdovin VS; Starosyla SA; Borysenko IP; Prykhod'ko AO; Lukashov SS; Bilokin YV; Bdzhola VG; Yarmoluk SM
    Bioorg Chem; 2020 Sep; 102():104062. PubMed ID: 32683178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
    Gu B; Johnston VK; Gutshall LL; Nguyen TT; Gontarek RR; Darcy MG; Tedesco R; Dhanak D; Duffy KJ; Kao CC; Sarisky RT
    J Biol Chem; 2003 May; 278(19):16602-7. PubMed ID: 12554734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.
    Picarazzi F; Vicenti I; Saladini F; Zazzi M; Mori M
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of RNA binding by the hepatitis C virus RNA-dependent RNA polymerase.
    Kim YC; Russell WK; Ranjith-Kumar CT; Thomson M; Russell DH; Kao CC
    J Biol Chem; 2005 Nov; 280(45):38011-9. PubMed ID: 16166071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into structural dynamics of allosteric binding sites in HCV RNA-dependent RNA polymerase.
    Mittal L; Kumari A; Suri C; Bhattacharya S; Asthana S
    J Biomol Struct Dyn; 2020 Apr; 38(6):1612-1625. PubMed ID: 31057089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.
    Haudecoeur R; Peuchmaur M; Ahmed-Belkacem A; Pawlotsky JM; Boumendjel A
    Med Res Rev; 2013 Sep; 33(5):934-84. PubMed ID: 22893620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
    Shi ST; Herlihy KJ; Graham JP; Nonomiya J; Rahavendran SV; Skor H; Irvine R; Binford S; Tatlock J; Li H; Gonzalez J; Linton A; Patick AK; Lewis C
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2544-52. PubMed ID: 19307358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficiency of incorporation and chain termination determines the inhibition potency of 2'-modified nucleotide analogs against hepatitis C virus polymerase.
    Fung A; Jin Z; Dyatkina N; Wang G; Beigelman L; Deval J
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3636-45. PubMed ID: 24733478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and functional characterization of the nascent RNA contacting residues of the hepatitis C virus RNA-dependent RNA polymerase.
    Vaughan R; Fan B; You JS; Kao CC
    RNA; 2012 Aug; 18(8):1541-52. PubMed ID: 22736798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CX-6258 hydrochloride hydrate: A potential non-nucleoside inhibitor targeting the RNA-dependent RNA polymerase of norovirus.
    Liu Y; Li Q; Shao H; Mao Y; Liu L; Yi D; Duan Z; Lv H; Cen S
    Virology; 2024 Jul; 595():110088. PubMed ID: 38643657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.
    Lim SP; Noble CG; Seh CC; Soh TS; El Sahili A; Chan GK; Lescar J; Arora R; Benson T; Nilar S; Manjunatha U; Wan KF; Dong H; Xie X; Shi PY; Yokokawa F
    PLoS Pathog; 2016 Aug; 12(8):e1005737. PubMed ID: 27500641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conformational mimetic approach for the synthesis of carbocyclic nucleosides as anti-HCV leads.
    Kasula M; Balaraju T; Toyama M; Thiyagarajan A; Bal C; Baba M; Sharon A
    ChemMedChem; 2013 Oct; 8(10):1673-80. PubMed ID: 23943612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.
    Olsen DB; Eldrup AB; Bartholomew L; Bhat B; Bosserman MR; Ceccacci A; Colwell LF; Fay JF; Flores OA; Getty KL; Grobler JA; LaFemina RL; Markel EJ; Migliaccio G; Prhavc M; Stahlhut MW; Tomassini JE; MacCoss M; Hazuda DJ; Carroll SS
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3944-53. PubMed ID: 15388457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds.
    Tramontano E
    Mini Rev Med Chem; 2008 Oct; 8(12):1298-310. PubMed ID: 18855743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication.
    Caleffi GS; Rosa AS; de Souza LG; Avelar JLS; Nascimento SMR; de Almeida VM; Tucci AR; Ferreira VN; da Silva AJM; Santos-Filho OA; Miranda MD; Costa PRR
    J Nat Prod; 2023 Jun; 86(6):1536-1549. PubMed ID: 37257024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Tedesco R; Shaw AN; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Fitch DM; Gates A; Gerhardt WG; Halegoua DL; Han C; Hofmann GA; Johnston VK; Kaura AC; Liu N; Keenan RM; Lin-Goerke J; Sarisky RT; Wiggall KJ; Zimmerman MN; Duffy KJ
    J Med Chem; 2006 Feb; 49(3):971-83. PubMed ID: 16451063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.